The Latest Cardiac and Vascular News
Randomized Disrupt PAD III Study Finds Superior Vessel Preparation Leads to Excellent Long-Term Outcomes and Preserved Future Treatment Options SANTA CLARA, Calif., May 19, 2022 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today […]
BEAUFORT, S.C.–(BUSINESS WIRE)–Research published by THE SAGE GROUP examines PAD disparities in African Americans and the contributing factors, as well as quantifies PAD prevalence in AA. “While it is well known that African Americans have a higher prevalence of PAD, prior to this publication, there were no estimates of the […]
WAYNE, Pa., May 18, 2022 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today has announced that it received Health Canada approval for the MANTA® Vascular Closure Device – the first commercially available biomechanical vascular closure device designed specifically for large bore femoral arterial access […]
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (NASDAQ: ABMD), a leader in breakthrough heart, lung and kidney support technologies, will feature the most recent Impella research and technological advances aimed at improving outcomes for acute myocardial infarction cardiogenic shock (AMICS) patients during the Society for Cardiovascular Angiography and Interventions (SCAI) 2022 Scientific Sessions, May 19 […]
Q3 Medical Devices Bi-Directional Stent, QualiMed Innovative Medizinprodukte GmbH, Winsen, Germany Results Published DUBLIN, May 17, 2022 /PRNewswire/ — Journal of Endovascular Therapy, 2022 (Impact factor 3.487 source Sage Journals) with title “Stents with torsional strength for Superficial Femoral artery disease. The prospective Q3-Registry” by Thieme et al: “The Q3 SELF-EXPANDING stent offers a novel patented Bi-Directional design providing for a new way of flexibility and torsional conformability that is highly durable and crush resistant working in unison […]
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Reflow Medical, Inc. announces that it has completed patient enrollment in the DEEPER OUS clinical trial (NCT03807531) for the company’s Temporary Spur Stent System, a novel device that features a retrievable stent designed for complex infrapopliteal disease. 106 patients have now been enrolled in the prospective, nonrandomized […]
– The eTrieve™ catheter for removing blood clots, based on electric fields, met safety and feasibility endpoints – Data, showing significant reduction RV/LV ratio and alleviation of PE associated symptoms, presented at Biomed Israel 2022 OR YEHUDA, Israel, May 10, 2022 /PRNewswire/ — Magneto Thrombectomy Solutions (Magneto), a medical devices company developing innovative thrombectomy solutions for the […]
Access Vascular’s transformational biomaterial catheters named “Best New Technology Solution” for ability to dramatically improve vascular access medical and economic outcomes BILLERICA, Mass., May 10, 2022 (GLOBE NEWSWIRE) — Access Vascular, Inc. (AVI) today announced it has been named “Best New Technology Solution – Drug Delivery” in the 2022 MedTech Breakthrough […]
Phase 3 DiSCOVER clinical trial initiation expected by end of Q2 2022 NEWTON, Mass., May 09, 2022 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced […]
VERVE-101 Preclinical Data Package Supports Company’s Global Development Strategy and Regulatory Submissions for Clinical Trials in Patients with HeFH Single Intravenous Infusion of VERVE-101 Clinical Formulation Led to Mean 68% Reduction in Plasma LDL-C in NHPs Out to One-Year with Good Tolerability; VERVE-101 Precursor Formulation Led to Durability of LDL-C […]
